Population
Rhabdomyosarcoma (RMS) cells
Design
Preclinical
Authors
Loading...
May support PHB2 as a target in rhabdomyosarcoma; leaves open translation from animal data.
Prohibitin-2 is required for IGFBP-6-induced rhabdomyosarcoma cell migration, suggesting it may be a novel target to inhibit cancer cell migration.
Fu et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: